nephritis in 11, nephrosclerosis in two, polycystic kidney in concentration in the serum of ESRD patients were measured according to methods previously reported [4, 15] . one, gouty kidney in one, and unknown in four.
The twenty-seven ESRD patients were divided into three groups based on the exposure to dialysis.
Statistical analysis
A: Patients in the predialysis stage.Thirteen patients without severe clinical signs or symptoms of uraemia were managed Results are presented as the mean±standard deviation (SD). on conservative treatment. At the time of study, nine patients Statistical analysis was performed by an analysis of variance, had undergone surgery for creation of an arteriovenous and Student's t test for unpaired variables. A P value less fistula and all nine started dialysis within 3 months after than 0.05 was considered significant. surgery. The remaining four subjects subsequently underwent insertion of an intraperitoneal catheter for continuous ambulatory peritoneal dialysis (CAPD).
Results

B:
Patients at the initiation phase of regular dialysis treatment.
Seven patients with severe clinical signs or symptoms of Comparison of TBARS between the ESRD group and uraemia were at the start of regular dialysis treatment the control group ( RDT ). All of them had commenced emergency HD by As shown in Figure 1 , the concentration of TBARS in double-lumen catheters within 1 month before they undersubcutaneous fat tissue in the ESRD group (n=27) went surgery for arteriovenous fistulae. The seven patients at the initiation phase of RDT were dialysed three times was 1.223±0.636 nmol/mg, whereas the level in the weekly with cuprophane membranes ( 0.8 m2), each session control group (n=11) was 0.097±0.054 nmol/mg. lasting 3 h. The dialysate used was Kinderly AF-2 (bicarbon-There was a statistically significant difference between ate-based, Fuso Pharmaceutical Co., Osaka, Japan).
the two groups (P<0.001). The concentrations of serum urea nitrogen and serum creatinine were C: Patients undergoing regular dialysis treatment. The other 87.4±32.4 and 9.1±3.2 mg/dl in the ESRD group seven patients were undergoing RDT with a mean duration of 57.3 months ( 22-120 months). They were clinically stable respectively, and 15.9±3.4 and 0.8±0.1 mg/dl in the except for shunt troubles, at which time they underwent control group, as shown in Table 1 . There were statistsurgery for new arteriovenous fistulae (n=4) or catheter ically significant differences between the two groups insertions for CAPD (n=2 ). The patients undergoing RDT (P<0.001) in serum urea nitrogen and serum creatinine were dialysed three times weekly, each session lasting 3 or levels. There was no significant difference in age. 4 Figure 2 . There was no significant difference in age, of the left elbow in 1, giant-cell tumour of the left radius bone in 1 ) were examined. Both of the groups were informed of the aims of the study, and we obtained specimens after getting written consent from the patients.
Specimens and analytical procedures
Fat specimens were taken from the ESRD patients when they underwent interventions for arteriovenous fistula (n= 21 ) or for insertion of a catheter for CAPD (n=6). Fat specimens from the controls were taken when they had other miscellaneous surgical interventions. Samples were kept frozen at −70°C until used for the measurement of TBARS [15] . Blood samples were drawn from the arterial side of the arteriovenous fistula of patients undergoing RDT before HD and from the antecubital veins of the other ESRD patients and controls. Serum total protein, albumin, urea nitrogen, creatinine, uric acid, GOT, GPT, LDH, alkaline phosphatase, total and HDL cholesterol, triglyceride, glucose, total calcium, inorganic phosphorus, Na, K, and Cl were determined Fig. 1 . Comparison of the content of lipid peroxides as measured by an autoanalyser (Hitachi 736-15, Japan). Serum iron was by thiobarbituric acid reactive substance (TBARS, mean±SD) in measured colorimetrically and serum ferritin by an enzyme subcutaneous fat tissue between control subjects (n=11) and those immunoassay. Red and white blood cells, haemoglobin, with end-stage renal disease ( ESRD, n=27). The TBARS levels of haematocrit, and platelets were determined by an autoana-subcutaneous fat tissue are significantly higher in ESRD patients than in controls (P<0.001).
lyser (Coulter STKS, USA). TBARS and methylguanidine There are statistically significant differences between two groups in serum urea nitrogen and creatinine levels (P<0.001) and no significant differences in age, serum total cholesterol, and triglyceride levels. Values are expressed as mean±SD. NS, not significant. serum urea nitrogen, and serum creatinine levels between the two groups ( Table 2 ) .
Influence of the exposure to dialysis
The ESRD patients were divided into three groups based on the exposure to dialysis, i.e. patients in the predialysis stage on conservative treatment (n=13), patients at the initiation phase of RDT (n=7), and patients undergoing RDT (n=7). There was a tendency for the levels of TBARS in the patients undergoing RDT to be lower than those in the patients at the initiation phase of RDT and those in the predialysis Fig. 3 . Comparison of the content of lipid peroxides in subcutaneous fat tissue among the three groups separated according to the exposure stage, though there were no significant differences to dialysis. TBARS levels of patients undergoing regular dialysis among the three groups ( Figure 3 ). As shown in treatment ( RDT ) (n=7) tend to be lower than those of patients at Table 3 , there were also no significant differences in the initiation phase of RDT (n=7 ) and those of patients in the age, serum urea nitrogen, and serum creatinine among predialysis stage on conservative treatment (n=13 ). There are no significant differences among the three groups.
the three groups. The patients with end-stage renal disease ( ESRD) were divided into three groups based on the exposure to dialysis, i.e. patients in the predialysis stage on conservative treatment, patients at the initiation phase of regular dialysis treatment ( RDT ), and patients on RDT.
There are no significant differences in age, serum urea nitrogen, creatinine, total cholesterol and triglyceride levels among the three groups.
Correlations among serum TBARS, methylguanidine, betic and non-diabetic ESRD patients. Generally and TBARS in fat tissue in the ESRD group speaking, diabetic patients seem to be in a hyperoxidative state and this tendency could bring about arterio-TBARS levels in fat tissue in the ESRD group did not sclerosis and vascular damage. Our findings do not correlate with serum levels of TBARS (r=−0.023) or support this speculation. One possible mechanism for methylguanidine (r=−0.141) (not shown).
a decreased vulnerability to oxygen damage in the diabetic group is the protection afforded by high concentrations of glucose in the circulating blood.
Discussion
In this study no significant differences were found among the three groups divided according to the Recent studies have revealed that uraemic patients are duration of HD; however, TBARS levels of patients in a highly peroxidative state [1, 2] in addition to other undergoing RDT tend to be lower than those of pathological conditions. Several markers which predict patients at the initiation phase of RDT and those of this peroxidative tendency are proposed such as conjug-patients in the predialysis stage on conservative treatated diene [16 ] , antioxidative enzymes [17 ], methylgu-ment. This is in agreement with our hypothesis that anidine as a peroxidative product of creatinine [4, 6] , haemodialysis improves the antioxidant activity of serum antioxidant activity [8, 11] , and lipid peroxides patients undergoing RDT [9] . This study did not [9] [10] [11] [12] [13] [14] [16] [17] [18] [19] . In all these markers, lipid peroxides are address the role played by various dialyser membranes, thought to reflect reliably the peroxidative tendency whose differences in permeability and biocompatibility and are employed in several studies. In this study we might be important. This could well be the subject of focused on subcutaneous fat tissue, since it is questionan expanded series of observations. able whether the level of TBARS in plasma reflects the As we reported previously, methylguanidine did not redox state in vivo.
correlate with TBARS in the serum of ESRD patients Our findings show that the TBARS level in subcuta- [14] . Serum methylguanidine levels in this study also neous fat tissue of ESRD patients is also high as do not correlate with TBARS levels in fat tissue. One compared to that in serum and red blood cells. One possible explanation is that the species of reactive possible mechanism for this observation is that the oxygen involved in methylguanidine synthesis and lipid lipid peroxides are produced in subcutaneous fat tissue peroxidation is different. The species concerned with itself and products of TBARS are increased because methylguanidine synthesis is the hydroxyl radical [4 ] , serum antioxidant activity in patients with ESRD is while it is thought to be singlet oxygen [20 ] in lipid decreased [8, 11] . Another possibility is that the lipid peroxidation. Furthermore, serum TBARS levels did peroxides produced in other organs may accumulate not correlate with those in fat tissue. We reported that in fat tissue transported via circulating plasma. Since serum TBARS levels do not vary much, and even in we have already reported that lipid peroxidation by ESRD patients the values are almost within the normal rat liver microsomes is increased in renal failure [7] , range [14 ] . One of the reasons we measured TBARS the increase in TBARS levels in subcutaneous fat tissue in fat tissue in this study is the variability noted in the of patients with ESRD directly implies that antioxidant literature comparing serum TBARS in controls and activity is decreased in patients with ESRD.
ESRD subjects [9, 12, 13] . No significant differences in the TBARS levels of This study shows that TBARS levels in fat tissue subcutaneous fat tissue were found between the diaare significantly higher in ESRD patients than in betic and non-diabetic ESRD patients, although the healthy controls and that the values do not correlate TBARS levels in both groups were significantly higher with serum levels. Serum TBARS levels could be kept than those in controls. In fact, TBARS levels of the low by some protective mechanisms such as hepatic diabetic group tend to be lower than those of the nonmicrosomes which, as we have indicated, are capable diabetic group. There are no reports comparing TBARS levels in serum or other tissues between dia-of both TBARS generation and degradation [7 ] .
lipid peroxidation by rat liver microsomes in experimental renal TBARS levels in fat tissues may be a more sensitive organs transported via circulating blood. 9 . Fillit H, Elion E, Sullivan J, Sherman R, Zabriskie JB.
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